AbbVie (ABBV) is ending its partnership with Alphabet (GOOG) (GOOGL)-funded biotech company Calico Life Sciences after a decade, STAT’s Damian Garde reports. The moves, under which AbbVie will lay off chemists working on discovering new drugs, were detailed in internal emails sent Tuesday and viewed by STAT.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV: